Glow Blend

Provider-formulated combination protocol — formulation set at consultation.

Overview

The Glow Blend is a provider-formulated combination protocol. The specific formulation is determined at consultation based on individual goals and provider assessment. It is not a standardized product.

Mechanism

Composition varies. Anti-inflammatory and tissue repair-signaling properties of the component peptides are the basis for both skin health and recovery applications.

Clinical Considerations

• Formulation is determined at consultation. Not a standardized product.
• Individual response depends on formulation, consistency of use, and individual biology.
• Requires provider evaluation.

Potential Side Effects

• Side effects depend on the specific formulation determined at consultation.
• Injection site reactions standard for any SubQ protocol.
• Your provider will review the side effect profile of each component at time of prescription.

All prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.